Oxidoreductases Acting on CH-NH Group Donors
"Oxidoreductases Acting on CH-NH Group Donors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed.
| Descriptor ID |
D000587
|
| MeSH Number(s) |
D08.811.682.662
|
| Concept/Terms |
Oxidoreductases Acting on CH-NH Group Donors- Oxidoreductases Acting on CH-NH Group Donors
- Oxidoreductases Acting on CH NH Group Donors
- Secondary Amine Oxidoreductases
- Amine Oxidoreductases, Secondary
- Oxidoreductases, Secondary Amine
- Amine Oxidoreductases, Secondary Amine
|
Below are MeSH descriptors whose meaning is more general than "Oxidoreductases Acting on CH-NH Group Donors".
Below are MeSH descriptors whose meaning is more specific than "Oxidoreductases Acting on CH-NH Group Donors".
This graph shows the total number of publications written about "Oxidoreductases Acting on CH-NH Group Donors" by people in this website by year, and whether "Oxidoreductases Acting on CH-NH Group Donors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 2 | 1 | 3 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oxidoreductases Acting on CH-NH Group Donors" by people in Profiles.
-
Genetic variants in ALDH1L1 and GLDC influence the serine-to-glycine ratio in Hispanic children. Am J Clin Nutr. 2022 08 04; 116(2):500-510.
-
Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2. Am J Med Genet A. 2020 10; 182(10):2426-2431.
-
Identification of diverse astrocyte populations and their malignant analogs. Nat Neurosci. 2017 Mar; 20(3):396-405.
-
Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism. Cell Death Dis. 2014 Feb 20; 5:e1075.
-
Reduced folate carrier polymorphism (80A-->G) and neural tube defects. Eur J Hum Genet. 2003 Mar; 11(3):245-52.
-
Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res A Clin Mol Teratol. 2003 Mar; 67(3):154-7.
-
Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia. Am J Cardiol. 2002 Apr 15; 89(8):919-23.
-
Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet. 2002 Feb 15; 108(1):1-6.
-
Does prenatal screening for 5,10-methylenetetrahydrofolate reductase (MTHFR) mutations in high-risk neural tube defect pregnancies make sense? Genet Test. 2002; 6(1):47-52.
-
Polymorphisms in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg. 2001 Dec; 11 Suppl 1:S14-7.